PharmTech LCGC Sciex Webinar 11.10
|Articles|September 30, 2011

Agilent CrossLab

Agilent product profile

Agilent CrossLab is the new, fast growing portfolio from Agilent Technologies, supplying chromatography instrument supplies, for your Non-Agilent instruments.

Agilent CrossLab supplies are manufactured specifically to perform seamlessly, with the variety of analytical instruments in your lab, including GCs from former Varian, Bruker, PerkinElmer, Shimadzu, and Thermo Scientific.

You’ll find the same outstanding quality, you expect from Agilent Technologies, with Agilent CrossLab autosampler vials, caps, septa and inserts.

Visit us at www.agilent.com/chem/saveonvials to save up to 25% on CrossLab vials.

Agilent CrossLab Ultra Inert Liner deactivation process, developed for high sensitivity analysis, provides extreme surface inertness – even for liners containing glass wool.

Ultra Inert chemistry was developed using a suite of tests specifically designed to stress, then evaluate liner activity, resulting in liners featuring:

• Reproducibility - highest level and consistent inertness for active compounds such as acids and bases

• Robustness - tested with a sequence of 100 injections of Endrin/DDT with

• Reliability - lot-tested for inertness to ensure consistent and efficient deactivation using both acidic and basic probes at trace level (2ng) on column, with low to no bleed or background contamination

Request your FREE Ultra Inert Liner here www.agilent.com/chem/qualify-free-liner

To view the entire Agilent CrossLab portfolio click here.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.